NCT04157985 Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors Status COMPLETED Phase PHASE3
NCT04149691 Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies Status RECRUITING Phase PHASE1
NCT04145141 National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04137289 A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT04100694 Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor Status APPROVED_FOR_MARKETING Phase N/A
NCT04099888 PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer Status TERMINATED Phase PHASE2
NCT04077372 Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers Status TERMINATED Phase NA
NCT04076761 Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma Status TERMINATED Phase PHASE2
NCT04066491 Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC Status TERMINATED Phase PHASE2/PHASE3
NCT04059562 Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT04028479 The Registry of Oncology Outcomes Associated with Testing and Treatment Status COMPLETED Phase N/A
NCT03999593 Long-term Morbidity After Surgery for Perihilar Cholangiocarcinoma Status COMPLETED Phase N/A
NCT03991832 Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03951324 Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study Status UNKNOWN Phase N/A
NCT03943043 Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT03924466 Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients Status RECRUITING Phase PHASE2
NCT03907852 Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) Status UNKNOWN Phase N/A
NCT03895970 Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors Status COMPLETED Phase PHASE2